|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 1/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2704798 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12721093.8 |
| Date of filing the European patent application | 2012-05-02 | |
| (97) | Date of publication of the European application | 2014-03-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-12 |
| (46) | Date of publication of the claims translation | 2017-10-25 |
| (86) | Number | PCT/US2012/036072 |
| Date | 2012-05-02 |
| (87) | Number | WO 2012/151248 |
| Date | 2012-11-08 |
| (30) | Number | Date | Country code |
| 201161481533 P | 2011-05-02 | US | |
| 201161550545 P | 2011-10-24 | US | |
| 201261585859 P | 2012-01-12 | US |
| (72) |
DILUZIO, Willow, US
TRUONG, Nobel T., US
VARGA, Csanad M., US
PALANIAPPAN, Vaithianathan, US
BROWN, Jason, US
FOX, Irving H., US
SCHOLZ, Catherine, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-alfa4beta7 antikūno kompozicija |
| FORMULATION FOR ANTI- ALPHA4BETA7 ANTIBODY |
| Payment date | Validity (years) | Amount | |
| 2026-04-21 | 15 | 289.00 EUR |
| 2027-05-02 |